According to Iovance Biotherapeutics 's latest financial reports the company's current revenue (TTM ) is ₹7.71 Billion. In 2023 the company made a revenue of ₹98.98 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.